long-term effects of glp-1 receptor agonists GI Adverse Glucagon-Like Peptide-1 Managing Side Effects of GLP-1
Description
These trials aimed to explore Ozempics potential for improving glycemic control, but it turns out Ozempic had a surprise up its sleevea hidden talent for shedding pounds
Trials 2019
McClean, P
Exenatides early success set important precedents
Liraglutide was approved by the FDA for marketing in the United States in 2010 and officially launched in China in 2011
BMJ Open, 14 (10): e089862
